That's important, since the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. In other words, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error procedure (second wave). Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're developed to do. This was a development nearly no one discovered. But it's going to have extensive ramifications for curing illness. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be plenty of investment chances in this space, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (the legacy report prediction). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it drew back possibly considerably prior to going higher - biotech stock. I have actually been covering bitcoin for a very long time now. One of the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were mainly educating readers. But that's not the big concern any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a trusted 170-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown predictions 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are a lot of excellent private companies on the edge of hitting the general public markets And I have actually been dealing with a new way for you to invest even prior to these companies go public.
This chance has actually been building over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to reserve your area free of charge.
Emma Walsh here, handling editor of the Diary. Regular Diary readers understand that tech isn't our usual beat (genetic sequencing companies jeff brown). And when it comes to tech investing, we leave it to the experts. Fortunately, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing professionals we know (jeff brown 1 biotech company). In reality, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the big picture and anticipate what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These trends are experiencing rapid growth and developing amazing opportunities for investors. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. artificial intelligence. But in spite of what lots of readers might think, this is a pattern that's simply beginning. Even though the COVID-19 pandemic interfered with supply chains in 2015, an outstanding 250 million 5G-enabled devices were still offered.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown genetic sequencer stock). Losing two months of production and sales actually impacts how numerous 5G devices are sold in the calendar year. When you consider all of that, selling 250 million systems is exceptional. More significantly, the hold-ups triggered by the pandemic produced a lots of suppressed demand. Which need is now going to be pushed into 2021. In truth, I anticipate that more than 500 million 5G devices will be shipped in 2021 - jeff brown stock predictions 2021. Which's not my only 5G forecast When I've discussed 5G in the past, I've explained its 3 different phases.
In Phase Two, 5G devices go on sale. 5G phones and other products start to reach customers. And in Phase Three, 5G services begin to be offered (self-driving cars). That's when we start to see applications operating on 5G networks. Consider things like enormous multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Phase 3 by this summertime. This begins something of a virtuous cycle: Many people do not actually care about the technology. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In truth, 5G is going to open a suite of incredible applications: self-driving automobiles, the Web of Things, robotic surgery, and more. All of these technologies require 5G. The financial investment opportunities going forward will be huge. Stepping far from 5G, the next important innovation I anticipate in 2021 is CRISPR genetic modifying. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it is among the most amazing developments in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software application.
The program can crash or not function correctly. CRISPR utilizes a similar concept however with our genetic code. "Typos" in our genome can result in illness. CRISPR can correct these "typos." For years, CRISPR was mainly a niche technology that wasn't well comprehended. And throughout that time, there were truly just three companies operating in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing real results. We're dealing with diseases and seeing that this innovation simply works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and providing incredible returns. This whole industry is successfully a greenfield chance.
There's room for many business to exist in this area. genetic sequencing companies jeff brown. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or 3 more genetic modifying business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things taking place at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software application can precisely forecast the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That is essential because the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and be efficient.
Historically, this has actually been a trial-and-error process. And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're developed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug treatments produced utilizing this technology. This was among those advancements that almost nobody saw. But it's going to have profound ramifications for curing illness. And, obviously, there will be a lot of investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it drew back maybe substantially prior to going greater. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever published was on bitcoin - jeff brown 2020 predictions. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my suggestion. But at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
But nobody is asking that question any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. self-driving cars. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the info depends on date as of February 2021, however we could not separately verify this claim. Offered Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this minute. Brown is best known for his sage-like ability to pick winning innovation stocks. He invested more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an outstanding perspective on the market. He's constantly on the hunt for new opportunities, and he shares much of his finest choices in the Near Future Report.
That's high appreciation, however it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he effectively predicted some of the most significant financial events of the previous 20 years. Although he does not appear to release his choices to the public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it best whenever, but Jeff Brown's precise predictions have made him legions of devoted fans. That states a lot about his capability. The Near Future Report is published by Brownstone Research, a prominent monetary research publisher. Brownstone Research study offers a number of research study services with a large range of specializations - jeff brown stock predictions.
The business is also affiliated with Bonner & Partners, another well-respected research publisher - what is the legacy report predicting. On its site, Brownstone states its mission is to provide retail financiers with professional-grade research study: "For too long, the very best investment research study has actually not been offered to specific financiers. It has actually been generally booked for investment banks, hedge funds, private equity, and high-net-worth customers. biotech stocks. The mission of Brownstone Research study is to make that kind of proprietary research offered to any financiers aiming to acquire an edge in the marketplaces. The goal is simple to provide unique and lucrative financial investment research study found no place else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also functions as the firm's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After years of steady success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout most of America. If you know even a little bit about the market, you understand that he has a reputation as a King Midas of sorts. jeff brown stock predictions. Everything he touches turns to gold! Jeff is well conscious of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In truth, Brown thinks S.A.V. future report review. could be "the biggest trend of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be weding 2 advanced technologies: expert system and electric vehicles. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing except the automobile market's Holy Grail. As you know, electrical vehicles and self-driving cars and truck stocks have actually been big this year, but the Wall Street maker has been huge on hype without much concrete result. Regardless of an extreme boost in competitors over the previous few years, Brown still thinks Musk has the very best opportunity of putting it all together.
tech could be the magic string that ties it all together. S.A.V. represents Shared Autonomous Vehicle, and it might be the future of transportation. Generally, this technology would enable you to rent your car as an autonomous, self-driving taxi when you're not using it. You merely leave the automobile and press a button on an app that informs the car to "sign up with the fleet." Next thing you understand, you're unwinding on your sofa while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a hefty piece of the profits. It sounds outrageous, but it might be closed than you believe.